General Manager, Alzheimer's US

Role: US General Manager for Alzheimer within GE Healthcare's Pharmaceutical Diagnostics business, responsible for defining and executing the US market strategy for Alzheimer disease diagnostics, with a focus on PET-imaging agents. Responsibilities: lead product launch, grow market share, drive revenue and margins; develop and implement account management models targeting nuclear medicine departments and referral physicians; foster relationships with KOLs, pharma partners, and radio pharmacies; oversee product lifecycle, market trends, and competitive landscape; collaborate cross-functionally with marketing, sales, and global teams; and develop high-performing commercial teams aligned with GEHC principles. Requirements: BA/BS, 10+ years in healthcare/MedTech sales, marketing, or product leadership; 3+ years in senior management; experience with novel PET agents and product lifecycle management; strong relationship-building, strategic, and ethical leadership skills; adept at cross-functional collaboration, negotiation, and P&L management. Preferred: team-building capabilities, financial reporting proficiency, familiarity with large sales processes, and a proven track record of accelerating sales. HighValue: Alzheimer disease diagnostics, PET imaging, product launch, healthcare/MedTech industry expertise, senior leadership, strategic partnerships, and cross-functional collaboration. WorkSetup: US-based, with relocation assistance; no specific travel requirement stated.